Apr 29, 2019
Ampio Pharmaceuticals Provides Regulatory Update
Mar 26, 2019
Ampio Pharmaceuticals Provides Corporate Update
Mar 06, 2019
Ampio Updates Regulatory Status for Ampion
Feb 06, 2019
Ampio Updates Status of Pivotal Clinical Trial of Ampion to be Carried Out Under a SPA
Dec 13, 2018
Ampio Updates Regulatory Status for Ampion
Nov 26, 2018
Ampio Updates Regulatory and Publication status for Ampion(TM)
Nov 07, 2018
Ampio Updates Regulatory and Clinical Status for Ampion(TM)
Oct 04, 2018
Ampio Provides Corporate Update
Sep 13, 2018
Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion(TM) accepted for Publication in "Clinical and Experimental Rheumatology(TM)"
Sep 04, 2018
Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals
Aug 08, 2018
Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Aug 06, 2018
Ampio Hosting Conference Call Tuesday, August 7, 4:30 pm EDT to Update the Preparation of the Biologics License Application (BLA) for Ampion(TM)
Jul 12, 2018
Ampio provides a Link to New Publication on the Mechanism of Action for Ampion(TM)
Jun 05, 2018
Ampio Provides Scientific Update and Links to Peer Review Publications
May 29, 2018
Ampio Updates Regulatory and IP Activities
May 22, 2018
Ampio Updates Scientific presentations and publications on Ampion(TM)
May 14, 2018
Ampio Provides Corporate Update
Apr 12, 2018
Ampio Updates Regulatory, Clinical and NYSE Activities
Mar 15, 2018
Ampio Pharmaceuticals Provides Corporate Update Following Conference Call